CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 8 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,145,000 | +5.8% | 7,100,000 | 0.0% | 0.02% | +31.6% |
| Q2 2022 | $3,916,000 | -19.6% | 7,100,000 | 0.0% | 0.02% | +46.2% |
| Q1 2022 | $4,869,000 | -7.7% | 7,100,000 | 0.0% | 0.01% | +44.4% |
| Q4 2021 | $5,276,000 | -3.8% | 7,100,000 | +16.4% | 0.01% | -18.2% |
| Q3 2021 | $5,486,000 | -14.7% | 6,100,000 | 0.0% | 0.01% | -26.7% |
| Q2 2021 | $6,434,000 | -7.3% | 6,100,000 | 0.0% | 0.02% | -25.0% |
| Q1 2021 | $6,943,000 | +31.3% | 6,100,000 | 0.0% | 0.02% | +11.1% |
| Q4 2020 | $5,288,000 | -9.5% | 6,100,000 | 0.0% | 0.02% | -40.0% |
| Q3 2020 | $5,842,000 | – | 6,100,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 21,000,000 | $13,956,000 | 0.88% |
| ARISTEIA CAPITAL, L.L.C. | 15,150,000 | $11,306,000 | 0.20% |
| LMR Partners LLP | 13,099,000 | $9,986,000 | 0.17% |
| UBS OCONNOR LLC | 8,250,000 | $5,595,000,000 | 0.08% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,100,000 | $3,916,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 250,000 | $164,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,025,000 | $1,605,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |